Efficiency of tocilizumab therapy for an exacerbation of systemic lupus erythematosus: A case report and a review of literature von Solovyev, S. K., Mesnyankina, A. A., Karateev, D. E., Luchikhina, E. L., Sigidin, Ya. A., Aseeva, E. A., Elonakov, A. V., Nasonov, E. L.

Volltext

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis von Mezenova, Tatyana Valentinovna, Tyurin, V P, Davidyan, S Yu, Kiryukhina, N A, Elonakov, A V

Volltext

AB1027 Use of Biologic Dmards in Russian Patients with Rheumatic Diseases: Analysis of The 6 Year-Experience of The Moscow Regional Research and Clinical Institute von Sokolova, M.V., Ivanitskiy, L.V., Elonakov, A.V.

Volltext

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study) von Nasonov, E L, Panasyuk, Elena Yuryevna, Buldakov, S G, Pavlova, A B, Knyazeva, L A, Kamalova, R G, Vinogradova, I B, Shikina, E A, Raskina, T A, Dmitriyeva, A A, Saikovsky, R S, Elonakov, A V, Amirdzhanova, V N, Aleksandrova, E N

Volltext

AB0663 Discontinuation of Anti-TNF-Alpha Therapy in Patients with Ankylosing Spondylitis von Vasiljeva, H.G., Elonakov, A.V., Gorenkov, R.V.

Volltext

KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES von Alekberova, Z S, Shekshina, N. S.V., Elonakov, A. V., Nassonova, V A

Volltext